Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Pharmacy professionals need thorough training and guidelines for safely preparing cytotoxic drugs.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Mild oxidative stress can prevent hair loss from chemotherapy.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Scalp cooling can effectively prevent hair loss during chemotherapy, improving patients' quality of life.

Nanocarriers can improve skin treatments after cancer therapy by enhancing antioxidant delivery and effectiveness.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

The review suggests renaming two herbs to avoid confusion and recommends more research for safe use.

Facelifts can lead to high patient satisfaction and a quick recovery when done correctly.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

Paternal drug exposure can harm fertility, pregnancy outcomes, and offspring health, with specific drugs linked to various reproductive issues.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Herbal remedies might help with hair loss but need more research for safety and effectiveness.

Testosterone pellets may help women's sexual function but have safety concerns and need more research.

Laser-assisted drug delivery is generally safe with mostly mild side effects.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

SVF may improve nanofat treatment for acne scars, but more research is needed.